EDITAS MEDICINE, INC. Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions
EDITAS MEDICINE, INC. (EDIT) had Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions of 0 security as of 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions · last filed 2025-05-12
- 2019-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions 3.00 item.
- 2019-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions 5.00 item.
- 2019-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions 2.00 item.
- 2019-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions 2.00 item.
item
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions |
|---|---|
| 2019-12-31 | 3.00 item 10-K · filed 2020-02-26 |
| 2019-09-30 | 5.00 item 10-Q · filed 2019-11-12 |
| 2019-06-30 | 2.00 item 10-Q · filed 2019-08-07 |
| 2019-03-31 | 2.00 item 10-Q · filed 2019-05-08 |
| 2018-12-31 | 38.00 item 10-K · filed 2019-03-01 |
| 2018-09-30 | 41.00 item 10-Q · filed 2018-11-08 |
security
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions |
|---|---|
| 2025-03-31 | 0.00 security 10-Q · filed 2025-05-12 |
| 2024-09-30 | 3.00 security 10-Q · filed 2024-11-04 |
| 2024-06-30 | 15.00 security 10-Q · filed 2024-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |